2018
DOI: 10.1038/s41598-018-29965-8
|View full text |Cite|
|
Sign up to set email alerts
|

MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia

Abstract: The study of anaphylactoid reactions during perioperative procedures and anaesthesia represents a diagnostic challenge for allergists, as many drugs are administered simultaneously, and approximately half of them trigger allergic reactions without a verifiable IgE-mediated mechanism. Recently, mast cell receptor MRGPRX2 has been identified as a cause of pseudo-allergic drug reactions. In this study, we analyse the ability of certain drugs used during perioperative procedures and anaesthesia to induce MRGPRX2-d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
79
2
3

Year Published

2019
2019
2024
2024

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 127 publications
(88 citation statements)
references
References 26 publications
4
79
2
3
Order By: Relevance
“…In a recent report in 2019 by IUPHAR/BPS, MRGPRX2 is listed as a Class A orphan GPCR for which preliminary evidence for an endogenous ligand has been published, or for which there exists a potential link to disease [17]. Now, it is known that direct activation of MRGPRX2 causes anaphylactoid shock in humans [1,18]. Unlike other GPCRs, MRGPRX2 can be activated by a plethora of chemicals including cationic amphiphilic drugs (tubocurarine, atracurium, icatibant, ciprofloxacin, and other fluoroquinolone antibiotics), insect venom chemical components (mastoparan and Polistes kinin), antimicrobial peptides (alpha-and beta-defensins and cathelicidins), secreted eosinophil products (eosinophil peroxidase and major basic protein), and neuropeptides (substance P, vasoactive intestinal peptide, neuropeptide Y, somatostatin, and cortistatin) [12,19].…”
Section: Introductionmentioning
confidence: 99%
“…In a recent report in 2019 by IUPHAR/BPS, MRGPRX2 is listed as a Class A orphan GPCR for which preliminary evidence for an endogenous ligand has been published, or for which there exists a potential link to disease [17]. Now, it is known that direct activation of MRGPRX2 causes anaphylactoid shock in humans [1,18]. Unlike other GPCRs, MRGPRX2 can be activated by a plethora of chemicals including cationic amphiphilic drugs (tubocurarine, atracurium, icatibant, ciprofloxacin, and other fluoroquinolone antibiotics), insect venom chemical components (mastoparan and Polistes kinin), antimicrobial peptides (alpha-and beta-defensins and cathelicidins), secreted eosinophil products (eosinophil peroxidase and major basic protein), and neuropeptides (substance P, vasoactive intestinal peptide, neuropeptide Y, somatostatin, and cortistatin) [12,19].…”
Section: Introductionmentioning
confidence: 99%
“…Mast cell MRGPRX2 plays a pivotal role in mediating pseudo-allergic reactions to several FDA approved drugs (3,(19)(20)(21)(22)(23)(24) and chronic inflammation associated with asthma (18), urticaria (7), and rosacea (6). We have identified a role for SOCE via STIM1 in regulating MRGPRX2 responses in mast cells.…”
Section: Discussionmentioning
confidence: 96%
“…This receptor is activated by the same ligands as MRGPRX2 and displays considerable homology with the human receptor. Interestingly, several FDA approved drugs serve as ligands for MRGPRX2 (3,(19)(20)(21)(22)(23)(24) and consequently cause pseudo-allergic reactions in humans; however, the mechanism(s) utilized by this receptor to promote mast cell activation is not well-understood.…”
Section: Introductionmentioning
confidence: 99%
“…The mechanism of pseudo-allergic reaction is not yet completely understood. Most of the time pseudo-allergic reaction is a candidate for consideration in IgE-independent allergic reactions [14,25], but given the symptoms of pseudo-allergy, the most likely explanation could be the hypothesis that certain antigens activate the effector cells of allergic inflammation, such as mast cells, without evidence of antigen-specific IgE, IgG or T cells [26]. Recent studies linked the pseudo-allergic reaction to a single receptor on mast cell, known as MRGPRX2 in human.…”
Section: Discussionmentioning
confidence: 99%